Delivery Order SPE2DB22D9367-SPE2DB25FSZ06
- Not listed
- The Defense Logistics Agency awarded a $25,106.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 31, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This delivery order, which carries an ultimate completion date of August 21, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million through November 2026. The award was made without set-aside designation, allowing DMS Pharmaceutical Group...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on July 21, 2025. The delivery order is for EXPAREL 266 mg/20 mL vials, a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management. The contract carries no set-aside designation, and DMS Pharmaceutical Group is competing as a small business...
- The Defense Logistics Agency awarded a $25.1K delivery order to DMS Pharmaceutical Group Inc. on July 21, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine product used for infiltration and nerve block anesthesia in surgical settings. This delivery order is issued without a set-aside designation and carries an ultimate completion date of August 11, 2025, under a firm fixed-price arrangement. The work will be performed in Park Ridge, Illinois, where DMS...
- The Defense Logistics Agency awarded a delivery order valued at $2,510.63 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. EXPAREL is a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management in surgical settings. The contract utilizes firm fixed-price pricing and carries an ultimate completion date of August 21, 2025. This delivery order...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at approximately $25.1K for EXPAREL 266 mg/20 mL vials. This award was issued as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its small business status. EXPAREL is...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 by the Defense Logistics Agency on July 25, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $50,212.60 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and was awarded on August 5, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,145.70 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $15,063.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract carries no...
- The U.S. government agency Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $21,417.30 to the woman-owned small business DMS Pharmaceutical Group Inc. for the supply of 4565295088 EXPAREL 133 MG/10 ML VIAL 10ML. This delivery order was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue delivery orders for a...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSZ06Delivery Order
The Defense Logistics Agency awarded a $20,085.04 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 30, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. This award carries an ultimate completion date of August 20, 2025, and will be performed in Park Ridge, Illinois. No set-aside designation was applied to this contract. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, was selected as the prime contractor and will deliver this pharmaceutical product directly to support the Defense Department's healthcare operations. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, a single-award vehicle valued at $499,999,999 and valid through November 2026 under the SPE2DB program. The IDC enables DLA to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables for military health facilities worldwide. DMS Pharmaceutical Group has demonstrated consistent success in federal pharmaceutical procurement through this partnership, leveraging its status as a woman-owned small business to compete effectively in DLA supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.1k | 7/30/25 |